Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Seroma 4Melanoma 3Postoperative Complications 2Breast Neoplasms 2Vulvar Neoplasms 1Stomach Neoplasms 1Lymphoma, Follicular 1Lymphocele 1Lymphedema 1Hemorrhage 1Carcinoma, Squamous Cell 1Bone Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 76Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Fibrin Tissue Adhesive × Clear all
NCT03733639 2020-07-23

Tisseel® as a Reinforcement of Esophagojejunal Anastomoses

Germans Trias i Pujol Hospital

Phase 4 Unknown
146 enrolled
Gastrointestinal

Stomach Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡